Predictive Oncology Stock Forecast - Period Momentum Indicator
| POAI Stock | USD 0.72 0.03 4.35% |
Predictive Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Predictive Oncology's historical fundamentals, such as revenue growth or operating cash flow patterns.
Predictive |
| Check Predictive Oncology Volatility | Backtest Predictive Oncology | Information Ratio |
Predictive Oncology Trading Date Momentum
| On November 23 2024 Predictive Oncology was traded for 0.72 at the closing time. The top price for the day was 0.75 and the lowest listed price was 0.69 . There was no trading activity during the period 0.0. Lack of trading volume on November 23, 2024 did not cause price change. The trading delta at closing time against the current closing price is 4.17% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare Predictive Oncology to competition |
Other Forecasting Options for Predictive Oncology
For every potential investor in Predictive, whether a beginner or expert, Predictive Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Predictive Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Predictive. Basic forecasting techniques help filter out the noise by identifying Predictive Oncology's price trends.Predictive Oncology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Predictive Oncology stock to make a market-neutral strategy. Peer analysis of Predictive Oncology could also be used in its relative valuation, which is a method of valuing Predictive Oncology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Predictive Oncology Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Predictive Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Predictive Oncology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Predictive Oncology Market Strength Events
Market strength indicators help investors to evaluate how Predictive Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Predictive Oncology shares will generate the highest return on investment. By undertsting and applying Predictive Oncology stock market strength indicators, traders can identify Predictive Oncology entry and exit signals to maximize returns.
Predictive Oncology Risk Indicators
The analysis of Predictive Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Predictive Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting predictive stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.01 | |||
| Standard Deviation | 5.68 | |||
| Variance | 32.22 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Predictive Oncology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Predictive Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Predictive Oncology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Predictive Oncology Stock:Check out Historical Fundamental Analysis of Predictive Oncology to cross-verify your projections. For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Predictive Oncology. If investors know Predictive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Predictive Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.96) | Revenue Per Share 0.416 | Quarterly Revenue Growth (0.43) | Return On Assets (0.56) | Return On Equity (1.49) |
The market value of Predictive Oncology is measured differently than its book value, which is the value of Predictive that is recorded on the company's balance sheet. Investors also form their own opinion of Predictive Oncology's value that differs from its market value or its book value, called intrinsic value, which is Predictive Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Predictive Oncology's market value can be influenced by many factors that don't directly affect Predictive Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Predictive Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Predictive Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Predictive Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.